Meinian Onehealth Healthcare Holdings Co., Ltd. (002044.SZ)
CNY 5.46
(-0.91%)
CNY 5.46
(-0.91%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 505.62 Million CNY | 206.96% |
| 2022 | -472.71 Million CNY | -394.51% |
| 2021 | 160.51 Million CNY | -70.87% |
| 2020 | 551.02 Million CNY | 177.2% |
| 2019 | -713.73 Million CNY | -186.97% |
| 2018 | 820.64 Million CNY | 33.7% |
| 2017 | 613.8 Million CNY | 81.11% |
| 2016 | 338.91 Million CNY | 30.21% |
| 2015 | 260.27 Million CNY | 425.67% |
| 2014 | 49.51 Million CNY | 894.15% |
| 2013 | -6.23 Million CNY | -110.22% |
| 2012 | 60.98 Million CNY | 3.5% |
| 2011 | 58.92 Million CNY | 153.83% |
| 2010 | 23.21 Million CNY | 22.29% |
| 2009 | 18.98 Million CNY | 45.17% |
| 2008 | 13.07 Million CNY | -48.07% |
| 2007 | 25.18 Million CNY | -3.34% |
| 2006 | 26.05 Million CNY | 14.78% |
| 2005 | 22.69 Million CNY | 10.61% |
| 2004 | 20.52 Million CNY | 2.2% |
| 2003 | 20.07 Million CNY | 24.12% |
| 2002 | 16.17 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 240.4 Million CNY | 239.37% |
| 2024 Q2 | 70.84 Million CNY | 124.72% |
| 2024 Q1 | -286.61 Million CNY | -202.35% |
| 2023 Q1 | -162.09 Million CNY | -55.83% |
| 2023 Q4 | 280.02 Million CNY | 29.97% |
| 2023 FY | 505.62 Million CNY | 206.96% |
| 2023 Q3 | 215.45 Million CNY | 21.49% |
| 2023 Q2 | 177.34 Million CNY | 209.41% |
| 2022 FY | -472.71 Million CNY | -394.51% |
| 2022 Q1 | -467.96 Million CNY | -253.42% |
| 2022 Q2 | -234.44 Million CNY | 49.9% |
| 2022 Q3 | 277.88 Million CNY | 218.53% |
| 2022 Q4 | -104.02 Million CNY | -137.43% |
| 2021 Q1 | -423.78 Million CNY | -139.57% |
| 2021 FY | 160.51 Million CNY | -70.87% |
| 2021 Q2 | -3.92 Million CNY | 99.07% |
| 2021 Q3 | 186.82 Million CNY | 4863.43% |
| 2021 Q4 | 305.01 Million CNY | 63.26% |
| 2020 Q2 | -183.87 Million CNY | 69.28% |
| 2020 Q4 | 1.07 Billion CNY | 303.72% |
| 2020 Q3 | 265.29 Million CNY | 244.28% |
| 2020 FY | 551.02 Million CNY | 177.2% |
| 2020 Q1 | -598.51 Million CNY | 52.41% |
| 2019 Q2 | 135.19 Million CNY | 214.23% |
| 2019 FY | -713.73 Million CNY | -186.97% |
| 2019 Q1 | -118.35 Million CNY | -129.1% |
| 2019 Q3 | 374.45 Million CNY | 176.97% |
| 2019 Q4 | -1.25 Billion CNY | -435.9% |
| 2018 Q2 | 267.92 Million CNY | 372.49% |
| 2018 FY | 820.64 Million CNY | 33.7% |
| 2018 Q1 | -98.32 Million CNY | -124.72% |
| 2018 Q4 | 406.77 Million CNY | 59.48% |
| 2018 Q3 | 255.07 Million CNY | -4.8% |
| 2017 FY | 613.8 Million CNY | 81.11% |
| 2017 Q1 | -105.79 Million CNY | -143.44% |
| 2017 Q4 | 397.73 Million CNY | 112.08% |
| 2017 Q3 | 187.54 Million CNY | 39.63% |
| 2017 Q2 | 134.31 Million CNY | 226.96% |
| 2016 FY | 338.91 Million CNY | 30.21% |
| 2016 Q1 | -129.06 Million CNY | -171.02% |
| 2016 Q2 | 106.61 Million CNY | 182.6% |
| 2016 Q4 | 243.53 Million CNY | 106.69% |
| 2016 Q3 | 117.82 Million CNY | 10.52% |
| 2015 Q3 | 114.91 Million CNY | 1744.59% |
| 2015 Q1 | 3 Million CNY | -71.0% |
| 2015 FY | 260.27 Million CNY | 425.67% |
| 2015 Q2 | 6.22 Million CNY | 107.45% |
| 2015 Q4 | 181.74 Million CNY | 58.16% |
| 2014 Q3 | 27.87 Million CNY | 285.59% |
| 2014 FY | 49.51 Million CNY | 894.15% |
| 2014 Q4 | 10.35 Million CNY | -62.84% |
| 2014 Q2 | 7.22 Million CNY | 78.39% |
| 2014 Q1 | 4.05 Million CNY | 109.39% |
| 2013 Q3 | 28.47 Million CNY | 627.11% |
| 2013 Q4 | -43.14 Million CNY | -251.55% |
| 2013 FY | -6.23 Million CNY | -110.22% |
| 2013 Q1 | 6.18 Million CNY | -73.32% |
| 2013 Q2 | 3.91 Million CNY | -36.67% |
| 2012 Q2 | 4.22 Million CNY | -21.34% |
| 2012 FY | 60.98 Million CNY | 3.5% |
| 2012 Q4 | 23.17 Million CNY | -17.86% |
| 2012 Q3 | 28.21 Million CNY | 568.58% |
| 2012 Q1 | 5.36 Million CNY | -80.6% |
| 2011 Q2 | 2.87 Million CNY | -40.0% |
| 2011 FY | 58.92 Million CNY | 153.83% |
| 2011 Q4 | 27.66 Million CNY | 17.25% |
| 2011 Q3 | 23.59 Million CNY | 721.08% |
| 2011 Q1 | 4.78 Million CNY | -33.26% |
| 2010 FY | 23.21 Million CNY | 22.29% |
| 2010 Q2 | 1.8 Million CNY | -47.72% |
| 2010 Q3 | 10.78 Million CNY | 497.52% |
| 2010 Q1 | 3.45 Million CNY | -45.29% |
| 2010 Q4 | 7.17 Million CNY | -33.45% |
| 2009 Q4 | 6.3 Million CNY | -26.35% |
| 2009 Q2 | 1.5 Million CNY | -42.5% |
| 2009 Q3 | 8.56 Million CNY | 470.69% |
| 2009 FY | 18.98 Million CNY | 45.17% |
| 2009 Q1 | 2.6 Million CNY | 21.3% |
| 2008 Q4 | 2.15 Million CNY | -70.42% |
| 2008 Q2 | 1.29 Million CNY | -45.07% |
| 2008 FY | 13.07 Million CNY | -48.07% |
| 2008 Q3 | 7.27 Million CNY | 461.81% |
| 2008 Q1 | 2.35 Million CNY | -39.72% |
| 2007 FY | 25.18 Million CNY | -3.34% |
| 2007 Q2 | 2.41 Million CNY | -39.96% |
| 2007 Q3 | 14.82 Million CNY | 512.53% |
| 2007 Q4 | 3.9 Million CNY | -73.62% |
| 2007 Q1 | 4.03 Million CNY | -21.73% |
| 2006 Q3 | 14.91 Million CNY | 523.75% |
| 2006 FY | 26.05 Million CNY | 14.78% |
| 2006 Q4 | 5.14 Million CNY | -65.48% |
| 2006 Q1 | 3.88 Million CNY | -43.77% |
| 2006 Q2 | 2.39 Million CNY | -38.41% |
| 2005 Q4 | 6.9 Million CNY | -45.62% |
| 2005 Q2 | 675.43 Thousand CNY | -72.06% |
| 2005 Q1 | 2.41 Million CNY | -66.27% |
| 2005 Q3 | 12.69 Million CNY | 1780.21% |
| 2005 FY | 22.69 Million CNY | 10.61% |
| 2004 Q3 | 10.94 Million CNY | 0.0% |
| 2004 Q4 | 7.16 Million CNY | -34.51% |
| 2004 FY | 20.52 Million CNY | 2.2% |
| 2003 FY | 20.07 Million CNY | 24.12% |
| 2002 FY | 16.17 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| C.Q. Pharmaceutical Holding Co., Ltd. | 654.95 Million CNY | 22.801% |
| Aier Eye Hospital Group Co., Ltd. | 3.35 Billion CNY | 84.947% |